Home » Authors » Jennifer Boggs

Articles by Jennifer Boggs

Acuity, Intradigm Working On Topical VEGF Inhibitor

June 10, 2005

By Jennifer Boggs

Biobanks seen accelerating move to personalized medicine

June 9, 2005

By Jennifer Boggs

Osiris brings in $50M to fund stem cell-based therapeutics

June 9, 2005

By Jennifer Boggs

Osiris Brings In $50M To Fund Stem Cell-Based Therapeutics

June 9, 2005

By Jennifer Boggs

Osiris Brings In $50M To Fund Stem Cell-Based Therapeutics

June 9, 2005

By Jennifer Boggs

BPersonalized iobanking Key To Future Of Medicine

June 8, 2005

By Jennifer Boggs

BPersonalized iobanking Key To Future Of Medicine

June 8, 2005

By Jennifer Boggs

Visudyne, Macugen, Lucentis; Wet AMD Landscape Changing

June 7, 2005

By Jennifer Boggs

Visudyne, Macugen, Lucentis; Wet AMD Landscape Changing

June 7, 2005

By Jennifer Boggs

Ziopharm Raises $18M In Series A For Cancer Drugs

June 6, 2005

By Jennifer Boggs

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 22, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 22, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...